The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gourley, T. S.
Right arrow Articles by Chang, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gourley, T. S.
Right arrow Articles by Chang, C.-H.
The Journal of Immunology, 2002, 168: 4414-4419.
Copyright © 2002 by The American Association of Immunologists

Aberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator1

Tania S. Gourley*, Dipak R. Patel*, Kevin Nickerson*, Soon-Cheol Hong{dagger} and Cheong-Hee Chang2,*,{dagger}

* Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109; and {dagger} Department of Microbiology and Immunology, Walther Oncology Center, Indiana University, Indianapolis, IN 46202

The MHC class II transactivator (CIITA) is a critical regulator of MHC class II genes and other genes involved in the Ag presentation pathway. CIITA-deficient mice lack MHC class II expression on almost all APCs. In this study, we show that these mice also have aberrant Fas ligand expression on both CD4 T cells and B cells. We found that Fas ligand expression was greatly increased on CIITA-deficient CD4 T cells during the Th1 differentiation process. However, both CIITA-deficient and control Th1 effector cells up-regulated Fas ligand to similar levels if cells were reactivated. The introduction of CIITA into primary CD4 T cells via retroviral infection resulted in a reduction in the level of Fas ligand and delay in apoptosis after activation. Interestingly, activated B cells from the CIITA-deficient mice also showed increased levels of Fas ligand that could be to some degree inhibited by the introduction of IL-4.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
M. Krawczyk, E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, E. Barras, and W. Reith
Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes
Nucleic Acids Res., January 28, 2007; 35(2): 595 - 605.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M.-J. Kwon, J.-W. Soh, and C.-H. Chang
Protein Kinase C{delta} Is Essential to Maintain CIITA Gene Expression in B Cells
J. Immunol., July 15, 2006; 177(2): 950 - 956.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. T. Litzinger, Y. Su, T. C. Lei, N. Soukhareva, and D. W. Scott
Mechanisms of Gene Therapy for Tolerance: B7 Signaling Is Required for Peptide-IgG Gene-Transferred Tolerance Induction
J. Immunol., July 15, 2005; 175(2): 780 - 787.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. B. Johnnidis, E. S. Venanzi, D. J. Taxman, J. P.-Y. Ting, C. O. Benoist, and D. J. Mathis
Chromosomal clustering of genes controlled by the aire transcription factor
PNAS, May 17, 2005; 102(20): 7233 - 7238.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. S. K. Yee, Y. Yao, Q. Xu, B. McCarthy, D. Sun-Lin, M. Tone, H. Waldmann, and C.-H. Chang
Enhanced Production of IL-10 by Dendritic Cells Deficient in CIITA
J. Immunol., February 1, 2005; 174(3): 1222 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. R. Patel, M. H. Kaplan, and C.-H. Chang
Altered Th1 Cell Differentiation Programming by CIITA Deficiency
J. Immunol., November 1, 2004; 173(9): 5501 - 5508.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Xu, L. Wang, G. Buttice, P. K. Sengupta, and B. D. Smith
Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon {gamma} (IFN-{gamma})
J. Biol. Chem., October 1, 2004; 279(40): 41319 - 41332.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
W. S. Park, Y. Bae, D. H. Chung, Y.-L. Choi, B. K. Kim, Y. C. Sung, E. Y. Choi, S. H. Park, and K. C. Jung
T cell expression of CIITA represses Th1 immunity
Int. Immunol., October 1, 2004; 16(10): 1355 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. S. K. Yee, Y. Yao, P. Li, M. J. Klemsz, J. S. Blum, and C.-H. Chang
Cathepsin E: A Novel Target for Regulation by Class II Transactivator
J. Immunol., May 1, 2004; 172(9): 5528 - 5534.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Cenci, G. Toraldo, M. N. Weitzmann, C. Roggia, Y. Gao, W. P. Qian, O. Sierra, and R. Pacifici
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-{gamma}-induced class II transactivator
PNAS, September 2, 2003; 100(18): 10405 - 10410.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. A. Otten, F. Tacchini-Cottier, M. Lohoff, F. Annunziato, L. Cosmi, L. Scarpellino, J. Louis, V. Steimle, W. Reith, and H. Acha-Orbea
Deregulated MHC Class II Transactivator Expression Leads to a Strong Th2 Bias in CD4+ T Lymphocytes
J. Immunol., February 1, 2003; 170(3): 1150 - 1157.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
E. V. Acosta Rodriguez, E. Zuniga, C. L. Montes, and A. Gruppi
Interleukin-4 biases differentiation of B cells from Trypanosoma cruzi-infected mice and restrains their fratricide: role of Fas ligand down-regulation and MHC class II-transactivator up-regulation
J. Leukoc. Biol., January 1, 2003; 73(1): 127 - 136.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.